Join us in transforming the way treatments are developed for Rare Diseases. Odylia’s goal is to raise $250,000 by the end of the year to empower patient groups and fund the next generation of rare disease drug development. If not you, if not us… then who?
Odylia is a unique nonprofit biotech bringing life-changing treatments to people with rare genetic disorders, regardless of prevalence or commercial interest. We help groups navigate the complexity of bringing treatments from the lab to patients.
Odylia is recreating how treatments can be brought to patients with rare disease. By building innovative partnerships and unique solutions, we are changing the paradigm of drug development for rare disease.
With little commercial interest in treatments for rare disease, Odylia relies on contributions from individuals, other nonprofit organizations, patient groups, and corporate donors to bring life-changing treatments to patients. Learn more about how you can make a difference.